We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only.
FLS: https://t.co/QUXfCXUNHv
Shorts
Every day, our scientists tackle challenging problems like the scalable synthesis of complex molecules. In this latest publication in Science Magazine, we share how we’re using #biocatalysis to manufacture orally available macrocyclic peptides. Learn more:
13,213 次观看
Today, we announced positive topline results from two of our Phase 3 clinical studies in #pneumococcal disease. Read more about our latest news: